CD4 and myelodysplastic syndrome: When compared to HC, E-MDS patients but not L-MDS ones, had a distinctly greater median percentage of committed Th17 cells among peripheral CD4+ cells (P = 0.002 vs. P = 0.34) (Fig. 2A).